The current valuation score of Arbutus Biopharma Corp is 9.48, ranking 31 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is 6.00, which is 4.82% below the recent high of 6.29 and 549.65% above the recent low of -26.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.